Our database has undergone a major update! We expect some minor teething issues, please let us know by using the Report an issue button at the top of every page if you spot anything that doesn't work.

• 1/5 BADBIR will be attending the BAD meeting on June 30th this year, for the full three days
• 2/5 Recruitment for patients commencing Sotyktu (deucravicitinib) ended on 20th May 2026
• 3/5 Read more: Changes to conventional cohort eligibility criteria
• 4/5 Our new 2026 Annual Update is coming soon...
• 5/5 Patients diagnosed with Generalised Pustular Psoriasis are eligible on Spevigo (spesolimab) or conventional treatment

Find out more on our website.